The present invention relates to pharmaceutical compositions comprising NGF or molecules with NGF-like activity for use in the treatment of traumatic brain injury by means of intranasal administration, a method for treating traumatic brain injury by means of intranasal administration of NGF or molecules with NGF-like activity, and an associated pharmaceutical kit.